Table 3.
AUROC | Without biomarkers | +NfL | p-value |
---|---|---|---|
Model A | 0.68 [0.61; 0.77] | 0.84 [0.78; 0.90] | p < 0.001 |
Model B | 0.79 [0.73; 0.86] | 0.86 [0.80; 0.93] | p = 0.029 |
Model C | 0.73 [0.66; 0.82] | 0.85 [0.78; 0.92] | p = 0.005 |
AUROC | Without biomarkers | +GFAP | p-value |
Model A | 0.68 [0.61; 0.77] | 0.85 [0.79; 0.91] | p < 0.001 |
Model B | 0.79 [0.73; 0.86] | 0.87 [0.80; 0.93] | p = 0.003 |
Model C | 0.73 [0.66; 0.82] | 0.86 [0.78; 0.92] | p = 0.001 |
AUROC | Without biomarkers | +NfL and GFAP | p-value |
Model A | 0.68 [0.61; 0.77] | 0.88 [0.83; 0.93] | p < 0.001 |
Model B | 0.79 [0.73; 0.86] | 0.88 [0.85; 0.94] | p < 0.001 |
Model C | 0.73 [0.66; 0.82] | 0.88 [0.84; 0.94] | p < 0.001 |